journal article·2025-11-12Open access

Topology Determines DNA Origami Diffusion in Intestinal Mucus

Matteo Tollemeto, Lars J. M. M. Paffen, Lasse H. E. Thamdrup, Anja Boisen, Jan van Hest, Tania Patiño Padial

Nano Letters· Volume 25· Issue 45

Abstract

Efficient nanomedicine delivery across mucosal barriers remains a challenge due to the complex and poorly understood relationship between nanoparticle design and mucus transport. Here, we present DNA origami as a platform to investigate how the nanoparticle shape and ligand patterning influence diffusivity in mucus. By decoupling these parameters while maintaining identical material composition, we systematically evaluated the diffusion of rod, icosahedral, and rectangular nanostructures by using high-resolution single-particle tracking. Our results reveal that diffusivity in mucus is not solely determined by shape or functionalization alone but by their interplay: while unmodified rods diffused poorly, their mobility increased significantly upon antibody functionalization, reaching a maximum at an intermediate ligand density. In contrast, rods and icosahedra exhibited less pronounced and nonoptimal responses to surface modification. These findings highlight the importance of topology-specific optimization in nanoparticle design and demonstrate the utility of DNA nanotechnology to uncover design rules for next-generation mucus-penetrating drug delivery systems.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery · Advanced Drug Delivery Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biomedical Engineering, Institute for Complex Molecular Systems, Eindhoven University of Technology, Het Kranenveld 14, 5600MB Eindhoven, The Netherlands

The Danish National Research Foundation and Villum Foundation’s Center IDUN, Department of Health Technology

Technical University of Denmark

Funding

Danmarks Grundforskningsfond · Novo Nordisk Foundation Center for Basic Metabolic Research · Villum Fonden · Nederlandse Organisatie voor Wetenschappelijk Onderzoek · ICMS · Irene Curie Fellowship

References (51)

Show source-provided references
1. 10.1038/nbt.333010.1038/nbt.3330 ↗
2. 10.1038/s41573-020-0090-810.1038/s41573-020-0090-8 ↗
3. 10.1038/s41565-020-0759-510.1038/s41565-020-0759-5 ↗
4. 10.1016/j.addr.2008.09.01210.1016/j.addr.2008.09.012 ↗
5. 10.1016/j.addr.2017.10.00910.1016/j.addr.2017.10.009 ↗
6. 10.1016/j.jconrel.2014.04.03310.1016/j.jconrel.2014.04.033 ↗
7. 10.1016/j.addr.2008.11.00210.1016/j.addr.2008.11.002 ↗
8. 10.1016/j.addr.2017.11.00210.1016/j.addr.2017.11.002 ↗
9. 10.1016/j.pscia.2023.10003110.1016/j.pscia.2023.100031 ↗
10. 10.1016/j.jconrel.2019.06.01510.1016/j.jconrel.2019.06.015 ↗
11. 10.1021/acsnano.2c1114710.1021/acsnano.2c11147 ↗
12. 10.1002/smll.20240364010.1002/smll.202403640 ↗
13. 10.1021/acs.nanolett.9b0484110.1021/acs.nanolett.9b04841 ↗
14. 10.1038/nature0458610.1038/nature04586 ↗
15. 10.1038/nature0801610.1038/nature08016 ↗
16. 10.1038/s43586-020-00009-810.1038/s43586-020-00009-8 ↗
17. 10.1038/natrevmats.2017.6810.1038/natrevmats.2017.68 ↗
18. 10.1038/s41565-023-01471-710.1038/s41565-023-01471-7 ↗
19. 10.1038/s41578-022-00517-x10.1038/s41578-022-00517-x ↗
20. 10.1038/s41565-024-01738-710.1038/s41565-024-01738-7 ↗
21. 10.1021/jacs.2c0852910.1021/jacs.2c08529 ↗
22. 10.1021/acs.nanolett.8b0066010.1021/acs.nanolett.8b00660 ↗
23. 10.1002/adbi.20220022410.1002/adbi.202200224 ↗
24. 10.1038/nbt.407110.1038/nbt.4071 ↗
25. 10.1038/s41596-022-00791-710.1038/s41596-022-00791-7 ↗
26. 10.1021/nn502058j10.1021/nn502058j ↗
27. 10.1038/s41565-023-01449-510.1038/s41565-023-01449-5 ↗
28. 10.1016/j.annonc.2019.10.00710.1016/j.annonc.2019.10.007 ↗
29. 10.1038/s41587-021-01024-010.1038/s41587-021-01024-0 ↗
30. 10.1002/adfm.20200291210.1002/adfm.202002912 ↗
31. 10.1002/smll.20250249610.1002/smll.202502496 ↗
32. 10.1021/acsnano.8b0463110.1021/acsnano.8b04631 ↗
33. 10.3109/1061186X.2015.108635910.3109/1061186X.2015.1086359 ↗
34. 10.1111/bcpt.1234210.1111/bcpt.12342 ↗
35. 10.1002/anie.20140599110.1002/anie.201405991 ↗
36. 10.1038/nature1458610.1038/nature14586 ↗
37. 10.1038/s41565-023-01507-y10.1038/s41565-023-01507-y ↗
38. 10.1038/nature1458610.1038/nature14586 ↗
39. 10.1039/D1NR07793G10.1039/D1NR07793G ↗
40. 10.1021/jacs.1c0229810.1021/jacs.1c02298 ↗
41. 10.1021/jacs.4c0209410.1021/jacs.4c02094 ↗
42. 10.1039/C4CP00292J10.1039/C4CP00292J ↗
43. 10.1021/acs.nanolett.6b0351510.1021/acs.nanolett.6b03515 ↗
44. 10.1016/j.bpj.2013.07.05010.1016/j.bpj.2013.07.050 ↗
45. 10.1016/j.ijpharm.2018.09.05510.1016/j.ijpharm.2018.09.055 ↗
46. 10.1016/j.addr.2008.09.00810.1016/j.addr.2008.09.008 ↗
47. 10.1208/s12248-012-9369-y10.1208/s12248-012-9369-y ↗
48. 10.1073/pnas.161640811410.1073/pnas.1616408114 ↗
49. 10.1016/j.ijpharm.2024.12479910.1016/j.ijpharm.2024.124799 ↗
50. 10.3390/gels801000110.3390/gels8010001 ↗
51. 10.1080/21645515.2021.193960510.1080/21645515.2021.1939605 ↗